Peptides
Every so often, a compound emerges from obscure research corners and earns serious scientific attention. Epithalon — a tetrapeptide derived from the pineal gland — is one of those compounds. With over 25 years of published research, a 2025 review in a major Western journal, and findings that include telomere elongation, melatonin
GLP-1
Orforglipron (Foundayo) received FDA approval in April 2026 as the first non-peptide oral GLP-1 receptor agonist for weight management. Here's everything you need to know about how it works, what the trials showed, and how it compares to injectable GLP-1 drugs.
Peptides
If you've spent any time researching growth hormone optimization, you've almost certainly come across CJC-1295. It's one of the most widely studied and clinically referenced GHRH analogs available today — and for good reason. Whether you want to understand the science behind it, compare the
Everything you need to know about liraglutide — how Victoza and Saxenda differ, full dosing protocols, side effects, clinical trial results, and how it stacks up against semaglutide and tirzepatide in 2026.
If you've been researching growth hormone peptides, you've almost certainly encountered ipamorelin — and for good reason. Unlike earlier growth hormone-releasing peptides (GHRPs) that came with a laundry list of unwanted side effects, ipamorelin delivers clean, selective GH stimulation without spiking cortisol, prolactin, or appetite. It'
GLP-1
A new class of weight-loss medication is rewriting the record books. Retatrutide (LY3437943), developed by Eli Lilly, is the world's first triple receptor agonist approved for obesity clinical trials — simultaneously targeting three metabolic pathways to produce weight loss that was previously considered impossible with a single drug. In
Peptides
If you've ever looked into treatments for low libido or sexual dysfunction, you may have come across PT-141 — a peptide that works unlike anything else on the market. Unlike Viagra or Cialis, which act on blood vessels, PT-141 (bremelanotide) targets the brain directly, activating the neural circuits responsible
GLP-1
A new class of obesity treatment is on the horizon. CagriSema, the combination of cagrilintide and semaglutide developed by Novo Nordisk, has generated enormous interest after delivering over 20% average weight loss in Phase 3 clinical trials. What Is CagriSema? CagriSema is a fixed-dose, once-weekly subcutaneous injection combining two active
Peptides
TB-500 is a synthetic analog of Thymosin Beta-4 — one of the most versatile healing peptides in research. This guide covers its mechanism of action, dosing protocols, the Wolverine Stack with BPC-157, and what the science actually supports.
Peptides
In the landscape of cognitive-enhancing peptides, Semax occupies a singular position. It is one of the few nootropic peptides with genuine clinical use — approved as a pharmaceutical in Russia and studied in controlled trials for stroke recovery, cognitive impairment, ADHD, and neurodegeneration. Its mechanism is unlike anything else in the
Peptides
Hexarelin stands out in the crowded field of growth hormone-releasing peptides (GHRPs) for one compelling reason: it is the most potent GHRP ever synthesized. While GHRP-6 and GHRP-2 have long dominated peptide protocols for growth hormone optimization, hexarelin produces significantly greater GH pulse amplitudes — and it comes with an unexpected
GLP-1
Tirzepatide (Mounjaro/Zepbound) is the most effective weight loss medication ever approved. This complete guide covers mechanism of action, SURMOUNT trial results, dosing, side effects, and how it compares to semaglutide.